Ex Parte COLLINS et alDownload PDFPatent Trials and Appeals BoardApr 29, 201914307598 - (D) (P.T.A.B. Apr. 29, 2019) Copy Citation UNITED STA TES p A TENT AND TRADEMARK OFFICE APPLICATION NO. FILING DATE FIRST NAMED INVENTOR 14/307,598 06/18/2014 Charles J. COLLINS 108120 7590 05/01/2019 Parker Highlander PLLC 1120 S. Capital of Texas Hwy Bldg 1, Suite 200 Austin, TX 78746 UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www .uspto.gov ATTORNEY DOCKET NO. CONFIRMATION NO. LUMN.P0070US.CP1.C2 5295 EXAMINER TURK,NEILN ART UNIT PAPER NUMBER 1798 NOTIFICATION DATE DELIVERY MODE 05/01/2019 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address(es): docket@phiplaw.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte CHARLES J. COLLINS, WILLIAM R. DEICHER, JARDEN E. KRAGER, ADAM R. SCHILFFARTH, and ROSS G. JOHNSON Appeal2018-006600 Application 14/307,598 1 Technology Center 1700 Before JEFFREY T. SMITH, BEYERL YA. FRANKLIN, and CHRISTOPHER C. KENNEDY, Administrative Patent Judges. SMITH, Administrative Patent Judge. DECISION ON APPEAL STATEMENT OF THE CASE This is an Appeal under 35 U.S.C. § 134(a) from the final rejection of claims 15-18 and 21. We have jurisdiction under 35 U.S.C. § 6(b). We reverse. 1 Appellant and the real party in interest is LUMINEX CORPORATION. (See App. Br. 3.) Appeal2018-006600 Application 14/307 ,598 The appealed invention relates to a system configured to perform imaging and analysis of particles to measure characteristics of the particles. (Spec. 3.) Independent claim 15 is representative of the appealed subject matter and reproduced below: 15. A system for analyzing a fluidic assay, comprising: a fluidic flow-through chamber comprising an imaging region, wherein the imaging region comprises a central point and a leading edge of the imaging region; a magnet comprising a polarizing axis and a leading edge of the magnet, wherein: the polarizing axis of the magnet is located downstream of the central point of the imaging region; and the leading edge of the magnet is located downstream relative to the leading edge of the imaging region; a mechanism for selectively positioning the magnet in proximity to the imaging region of the fluidic flow-through chamber, the mechanism comprising an actuator and a magnetic field strength sensor; an illumination subsystem configured to illuminate the imaging region of the fluidic flow-through chamber; and a photosensitive detection subsystem configured to image the imaging region of the fluidic flow-through chamber when illuminated; wherein an interior back portion of the imaging region of the fluidic flow-through chamber comprises a roughened surface. (App. Br. 12 (Claims Appendix).) 2 Appeal2018-006600 Application 14/307 ,598 The following rejections are presented for our review: I. Claims 15-17 and 21 are rejected under 35 U.S.C. § I03(a) as unpatentable over the combined teachings of Batishko (US 2004/0234898 Al; Nov. 25, 2004) and Hoet (US 2003/0170686 Al; Sept. 11, 2003). II. Claim 18 is rejected under 35 U.S.C. § I03(a) as unpatentable over the combined teachings of Batishko, Hoet, and Williams (US 2003/0186255 Al; Oct. 2, 2003). The complete statement of the rejections on appeal appear in the Final Office Action. (Final Act. 3-7.) OPINION Upon consideration of the evidence in this Appeal record, in light of the respective positions advanced by the Examiner and Appellants, we determine that Appellants have identified reversible error in the Examiner's rejection of independent claim 15. We add the following: The dispositive issue for this Appeal is: Did the Examiner err in determining that Batishko teaches or suggests "a fluidic flow-through chamber comprising an imaging region, wherein the imaging region comprises a central point and a leading edge of the imaging region" and "a magnet comprising a polarizing axis and a leading edge of the magnet" as required by independent claim 15?2 2 The Examiner cited Hoet and Williams to address other limitations of the claim not related to the dispositive issue. Consequently, a discussion of these references is unnecessary. 3 Appeal2018-006600 Application 14/307 ,598 Annotated Figure 6 from the Appeal Brief is reproduced below: Annotated FIG. 6 Annotated Figure 6 illustrates an imaging region 94, a central point 110 and leading edge 114 of the imaging region, a magnet 100 with a polarizing axis 108 and a leading edge 112. According to the Specification, the flow moves from inlet 96 to outlet 98, as such, the leading edge of a component is the edge closest to the inlet 96 ( e.g. the first edge of the component when moving from inlet 96 to outlet 98). (Spec. 42--45.) The Examiner finds Batishko discloses a magnetic flowcell system and method. (Final Act. 3-5.) According to the Examiner: Batishko discloses a fluidic flow-through chamber 46 comprising an array of flowcells 50, which each includes a fluid inlet 52 and outlet 54 (providing inlets and outlets as in cl. 17[)]; wherein it is noted that the imaging region is not particularly-structured at present and is given by way of a capability of the light source, wherein it is said that such light source is fully capable of providing excitation light such to an imaging region such that the widths of the input and output channels are tapered relative to the width of the imaging region. Examiner further asserts that the imaging region of Batishko is 4 Appeal2018-006600 Application 14/307 ,598 defined toward the left-hand side of the flow-through chamber and extending to the right therefrom up to and before the leading edge of the magnet 42 (left side of the magnet as seen in fig. 2). Herein, such imaging region has a center point and a leading edge, and the polarizing axis of the magnet is located downstream of the central point of the imaging region and the leading edge of the magnet (i.e. the left-edge as seen fig. 2) is located downstream relative to the leading edge of the imaging region (i.e. the furthest edge on the left side of the imaging region). Further, herein, the polarizing axis and leading edge of the magnet are both located to the right, i.e. "downstream", of the defined imaging region discussed above when viewing fig. 2 in plain. (Final Act. 3--4.) We cannot sustain the appealed rejections. The Examiner has failed to identify where Batishko describes or suggest a fluidic flow-through chamber comprising an imaging region, wherein the imaging region comprises a central point and a leading edge of the imaging region and a magnet comprising a polarizing axis and a leading edge of the magnet as required by independent claim 15. The Examiner, when explaining the rejection of claim 15, relies on Batishko's Figure 2 which is reproduced below: Fig. 2 Batishko, Fig. 2 5 Appeal2018-006600 Application 14/307 ,598 The Examiner has failed to adequately identify a specific imaging region in Batishko. According to the Examiner, the imaging region in Batishko is defined toward the left-hand side of the flow-through chamber and extending to the right therefrom up to and before the leading edge of the magnet 42. (Ans. 4.) Contrary to the Examiner's position, Batishko describes element 44 as a sensing arrangement that extends the entire length of the device shown in Figure 2, and sensor 72 is positioned in the center of the device. (See also Batishko ,r 29.) Consequently, the elements relied upon by the Examiner in rejecting independent claim 15 are not supported by the descriptions of Batishko . For the foregoing reasons and those stated in the Brief, we determine that the Examiner's conclusion of obviousness is not supported by facts. "Where the legal conclusion [ of obviousness] is not supported by facts it cannot stand." In re Warner, 379 F.2d 1011, 1017 (CCPA 1967). Accordingly, we cannot sustain the Examiner's decision to reject claims 15- 18 and 21. DECISION The rejections under 35 U.S.C. § 103(a) of claims 15-18 and 21 are reversed. REVERSED 6 Copy with citationCopy as parenthetical citation